(Q33943448)

30 July 2017

1 reference

title

Global immune disregulation in multiple sclerosis: from the adaptive response to the innate immunity (English)

1 reference

30 July 2017

8

1 reference

ORCID Public Data File 2021

30 July 2017

1 reference

author name string

Ristori G

1

1 reference

30 July 2017

Montesperelli C

2

1 reference

30 July 2017

Perna A

3

1 reference

30 July 2017

Cannoni S

4

1 reference

30 July 2017

Battistini L

5

1 reference

30 July 2017

Borsellino G

6

1 reference

30 July 2017

Riccio P

7

1 reference

30 July 2017

Chersi A

9

1 reference

30 July 2017

Pozzilli C

10

1 reference

30 July 2017

Buttinelli C

11

1 reference

30 July 2017

Salvetti M

12

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Journal of Neuroimmunology

30 July 2017

published in

1 reference

30 July 2017

volume

107

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

216-219

1 reference

Autoimmunity is a type I interferon-deficiency syndrome corrected by ingested type I IFN via the GALT system

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

The cognitive principle challenges clonal selection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

Human CD14 mediates recognition and phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

The instructive role of innate immunity in the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

H2-M3, a full-service class Ib histocompatibility antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

Innate immunity: the virtues of a nonclonal system of recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

Microbe exposure, innate immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

Give us this day our daily germs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

Effect of adjuvant therapy on development of diabetes in mouse and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

The inverse association between tuberculin responses and atopic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900219-8

7 January 2021

10.1016/S0165-5728(00)00219-8

Identifiers

DOI

1 reference

30 July 2017

1 reference